研報掘金丨東方證券:維持珀萊雅“買入”評級,兩大主力品牌保持良好競爭力
東方證券研報指出,珀萊雅兩大主力品牌目前保持良好的行業競爭力。各大平臺的618活動,正在火熱進行,階段性數據顯示,公司主品牌珀萊雅在天貓美妝618第一階段(5/16-5/26日)中穩居全行業第1名,在抖音5月美容護膚品牌榜中排第3名。公司彩妝品牌彩棠在5月抖音彩妝領域排名第5名,相比去年同期的第16名明顯提升。公司目前是所有國貨美妝中多品牌佈局最爲完善的集團之一。在5月舉行的年度股東大會上公司也表示,正考慮通過巴黎分公司實施海外併購,以進軍嬰童、香水及男士護膚等新領域。我們看好公司的長期發展空間。DCF目標估值112.78元,維持“買入”評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.